Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Hesdorffer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
JAMA Oncology|March 31, 2017
Cancer-Related AnxietyGleneara E Bates, Jadmin L Mostel, Mary Hesdorffer
Journal of Oncology Practice|November 19, 2016
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative ChemotherapyPaul H Sugarbaker, Kiran K Turaga, H Richard Alexander, et al.
Sarcoma|December 2, 2008
Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic LeiomyosarcomaMichelle S Boyar, Mary Hesdorffer, Mary Louise Keohan, et al.
Translational Oncology|March 10, 2015
Changing pattern in malignant mesothelioma survivalJennifer Faig, Suzanne Howard, Edward A Levine, et al.
Translational Lung Cancer Research|July 15, 2016
Approach to offering remote support to mesothelioma patients: the mesothelioma survivor projectGleneara E Bates, Anisah K Hashmi, Toby Bressler, et al.
Cancer|October 30, 2003
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcomaSusan M Talbot, Mary Louise Keohan, Mary Hesdorffer, et al.
Cancer Immunity|August 10, 2004
The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcomaMaha Ayyoub, Robert N Taub, Mary-Louise Keohan, et al.
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesotheliomaAlain C Borczuk, Robert N Taub, Mary Hesdorffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
JAMA Oncology|March 31, 2017
Cancer-Related AnxietyGleneara E Bates, Jadmin L Mostel, Mary Hesdorffer
Journal of Oncology Practice|November 19, 2016
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative ChemotherapyPaul H Sugarbaker, Kiran K Turaga, H Richard Alexander, et al.
Sarcoma|December 2, 2008
Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic LeiomyosarcomaMichelle S Boyar, Mary Hesdorffer, Mary Louise Keohan, et al.
Translational Oncology|March 10, 2015
Changing pattern in malignant mesothelioma survivalJennifer Faig, Suzanne Howard, Edward A Levine, et al.
Translational Lung Cancer Research|July 15, 2016
Approach to offering remote support to mesothelioma patients: the mesothelioma survivor projectGleneara E Bates, Anisah K Hashmi, Toby Bressler, et al.
Cancer|October 30, 2003
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcomaSusan M Talbot, Mary Louise Keohan, Mary Hesdorffer, et al.
Cancer Immunity|August 10, 2004
The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcomaMaha Ayyoub, Robert N Taub, Mary-Louise Keohan, et al.
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesotheliomaAlain C Borczuk, Robert N Taub, Mary Hesdorffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.
Pageof 3